Gene deletion from Plasmodium falciparum using FLP and Cre recombinases: Implications for applied site-specific recombination

International Journal for Parasitology

Volumn 41, Issue 1, 2011, Pages 117-123

  O'Neill, Matthew T ^a   Phuong, Thuan ^a   Healer, Julie ^a   Richard, Dave ^a   Cowman, Alan F ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Cre recombinase; FLP recombinase; Malaria; Plasmodium falciparum; Site specific recombination

Indexed keywords

CRE RECOMBINASE; DIHYDROFOLATE REDUCTASE; RECOMBINASE;

DRUG RESISTANCE; ENZYME; GENE EXPRESSION; GENOME; MALARIA; PARASITE; PROTOZOAN;

ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; GENE SEQUENCE; GENETIC RECOMBINATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; SEQUENCE ANALYSIS; SOUTHERN BLOTTING; TEMPERATURE DEPENDENCE;

DNA NUCLEOTIDYLTRANSFERASES; DRUG RESISTANCE; GENE DELETION; GENE KNOCKOUT TECHNIQUES; GENETICS, MICROBIAL; HUMANS; INTEGRASES; PEPTIDE SYNTHASES; PLASMODIUM FALCIPARUM; RECOMBINATION, GENETIC;

PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM;

EID: 78650171193     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.08.001     Document Type: Article

References (26)

1. Brecht S., Erdhart H., Soete M., Soldati D. Genome engineering of Toxoplasma gondii using the site-specific recombinase Cre. Gene 1999, 234:239-247.
2. Buchholz F., Ringrose L., Angrand P.O., Rossi F., Stewart A.F. Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res. 1996, 24:4256-4262.
3. Carvalho T.G.S., Thiberge H., Sakamoto H., Menard R. Conditional mutagenesis using site-specific recombination in Plasmodium berghei. Proc. Natl. Acad. Sci. USA 2004, 101:14931-14936.
4. Combe A., Giovannini D., Carvalho T.G., Spath S., Boisson B., Loussert C., Thiberge S., Lacroix C., Gueirard P., Menard R. Clonal conditional mutagenesis in malaria parasites. Cell Host Microbe 2009, 5:386-396.
5. Crabb B.S., Cooke B.M., Reeder J.C., Waller R.F., Caruana S.R., Davern K.M., Wickham M.E., Brown G.V., Coppel R.L., Cowman A.F. Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress. Cell 1997, 89:287-296.
6. Feil R., Brocard J., Mascrez B., LeMeur M., Metzger D., Chambon P. Ligand-activated site-specific recombination in mice. Proc. Natl. Acad. Sci. USA 1996, 93:10887-10890.
7. Fidock D.A., Wellems T.E. Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc. Natl. Acad. Sci. USA 1997, 94:10931-10936.
8. Kilby N.J., Snaith M.R., Murray J.A. Site-specific recombinases: tools for genome engineering. Trends Genet. 1993, 9:413-421.
9. Maier A.G., Braks J.A., Waters A.P., Cowman A.F. Negative selection using yeast cytosine deaminase/uracil phosphoribosyl transferase in Plasmodium falciparum for targeted gene deletion by double crossover recombination. Mol. Biochem. Parasitol. 2006, 150:118-121.
10. Maier A.G., Rug M., O'Neill M.T., Brown M., Chakravorty S., Szestak T., Chesson J., Wu Y., Hughes K., Coppel R.L., Newbold C., Beeson J.G., Craig A., Crabb B.S., Cowman A.F. Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell 2008, 134:48-61.
11. Mamoun C.B., Gluzman I.Y., Goyard S., Beverley S.M., Goldberg D.E. A set of independent selectable markers for transfection of the human malaria parasite Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 1999, 96:8716-8720.
12. Meissner M., Krejany E., Gilson P.R., de Koning-Ward T.F., Soldati D., Crabb B.S. Tetracycline analogue-regulated transgene expression in Plasmodium falciparum blood stages using Toxoplasma gondii transactivators. Proc. Natl Acad. Sci. USA 2005, 102:2980-2985.
13. Metzger D., Clifford J., Chiba H., Chambon P. Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. Proc. Natl. Acad. Sci. USA 1995, 92:6991-6995.
14. Mueller A.K., Labaied M., Kappe S.H., Matuschewski K. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Nature 2005, 433:164-167.
15. Nkrumah L.J., Muhle R.A., Moura P.A., Ghosh P., Hatfull G.F., Jacobs W.R., Fidock D.A. Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase. Nat. Methods 2006, 3:615-621.
16. O'Donnell R.A., Freitas-Junior L.H., Preiser P.R., Williamson D.H., Duraisingh M., McElwain T.F., Scherf A., Cowman A.F., Crabb B.S. A genetic screen for improved plasmid segregation reveals a role for Rep20 in the interaction of Plasmodium falciparum chromosomes. EMBO J. 2002, 21:1231-1239.
17. Roder J., Hickey W.F. Mouse models, immunology, multiple sclerosis and myelination. Nat. Genet. 1996, 12:6-8.
18. Rossant J., Nagy A. Genome engineering: the new mouse genetics. Nat. Med. 1995, 1:592-594.
19. Sauer B. Site-specific recombination: developments and applications. Curr. Opin. Biotechnol. 1994, 5:521-527.
20. Tarun A.S., Dumpit R.F., Camargo N., Labaied M., Liu P., Takagi A., Wang R., Kappe S.H. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. J. Infect. Dis. 2007, 196:608-616.
21. Ting L.M., Gissot M., Coppi A., Sinnis P., Kim K. Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. Nat. Med. 2008, 14:954-958.
22. van Dijk M.R., Douradinha B., Franke-Fayard B., Heussler V., van Dooren M.W., van Schaijk B., van Gemert G.J., Sauerwein R.W., Mota M.M., Waters A.P., Janse C.J. Genetically attenuated, P36p-deficient malarial sporozoites induce protective immunity and apoptosis of infected liver cells. Proc. Natl. Acad. Sci. USA 2005, 102:12194-12199.
23. VanBuskirk K.M., O'Neill M.T., De La Vega P., Maier A.G., Krzych U., Williams J., Dowler M.G., Sacci J.B., Kangwanrangsan N., Tsuboi T., Kneteman N.M., Heppner D.G., Murdock B.A., Mikolajczak S.A., Aly A.S., Cowman A.F., Kappe S.H. Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc. Natl Acad. Sci. USA 2009, 106:13004-13009.
24. van Schaijk B.C., Janse C.J., van Gemert G.J., van Dijk M.R., Gego A., Franetich J.F., van de Vegte-Bolmer M., Yalaoui S., Silvie O., Hoffman S.L., Waters A.P., Mazier D., Sauerwein R.W., Khan S.M. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. PLoS One 2008, 3:e3549.
25. Wu Y., Sifri C.D., Lei H.-H., Su X.-S., Wellems T.E. Transfection of Plasmodium falciparum within human red blood cells. Proc. Natl. Acad. Sci. USA 1995, 92:973-977.
26. Zhang Y., Riesterer C., Ayrall A.M., Sablitzky F., Littlewood T.D., Reth M. Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids Res. 1996, 24:543-548.